New Cancer Therapies Likely Following 'Orphan' Sleep Drug Findings
An inexpensive orphan drug used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center. Their novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more-effective cancer therapies. The findings are published in the Proceedings of the National Academy of Sciences. A research team led by corresponding author Carla Grandori, M.D., Ph.D... (Source: Health News from Medical News Today)

Patients' Blood Pressure Decreases With Behavioral Support From Peers, Staff
Behavioral support from peers and primary care office staff can help patients improve their blood pressure control by as much as starting a new drug, a new study found. Barbara J. Turner, M.D., M.S.Ed., M.A., M.A.C.P., of UT Medicine San Antonio, is the senior author. The randomized, controlled trial examined whether six months of intervention - behavioral support from peers and primary care office staff - could benefit African-American patients who had poor control of systolic pressure despite one to two years of prescriptions and office visits... (Source: Health News from Medical News Today)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div